Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic PBSCT in Metastatic Breast Cancer
NCT00074269Phase 2Terminated
- Sponsor
- University of California, San Diego
- Start
- Jul 2003
- Primary completion
- Mar 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic peripheral blood progenitor cells in breast cancer, sponsored by University of California, San Diego. Primary endpoints: Number of Participants With Adverse Events, Number of Participants With Long-term Engraftment of Allogeneic Stem Cells and Lymphocytes and 1 more. Started Jul 2003; status: terminated.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00074269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074269.